Long-term progressive multifocal leukoencephalopathy risk stratification in multiple sclerosis patients treated with natalizumab with positive John Cunningham virus index
Natalizumab can be used for long-term treatment of patients with MS even with positive JCV index if recommended precautions such as EID and frequent brain MRIs are followed.
Authors
- Aleksandra Podlecka‐Piętowska (ORCID: https://orcid.org/0000-0003-3940-4662)
- Natalia Szejko (ORCID: https://orcid.org/0000-0001-6160-9221)
- Monika Nojszewska (ORCID: https://orcid.org/0000-0003-4231-5636)
- Beata Zakrzewska‐Pniewska (ORCID: https://orcid.org/0000-0002-2193-1723)
Institutions
- Medical University of Warsaw (PL)
- Medizinische Hochschule Hannover (DE)
- Maternal and Child Health Care Hospital of Bao'an (CN)
- Sjællands Universitetshospital, Nykøbing F. (DK)
Publication Details
- Journal
- Neurologia i Neurochirurgia Polska
- Published
- 2025-11-25
- DOI
- https://doi.org/10.5603/pjnns.106188
- Primary Topic
- Polyomavirus and related diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00